Karyotype–phenotype associations in turner syndrome: a multicenter retrospective cohort study - Report - MDSpire

Karyotype–phenotype associations in turner syndrome: a multicenter retrospective cohort study

  • By

  • Rama Watad

  • Sara Al Jneibi

  • Sareea Al Remeithi

  • Rasha Hassan Beck

  • Noura Al Hassani

  • Asma Deeb

  • July 7, 2026

  • 0 min

Share

Clinical Report: Associations Between Karyotype and Phenotype in Turner Syndrome

Overview

This study investigates the associations between karyotype variations and clinical features in Turner syndrome (TS) patients. It highlights significant differences in spontaneous menarche rates and autoimmune hypothyroidism prevalence among different karyotype groups.

Background

Turner syndrome is a common sex chromosome disorder characterized by the absence or structural abnormalities of the second X chromosome. Understanding the relationship between karyotypes and clinical phenotypes is crucial for optimizing management and care strategies for affected individuals. Early diagnosis and treatment can significantly improve growth, pubertal development, and overall quality of life.

Data Highlights

CharacteristicFinding
Median age at diagnosis9.3 years
Classical monosomies44.2%
Mosaic cases18.6%
Structural abnormalities37.2%
Spontaneous menarche in 45, X individuals4.3%
Spontaneous menarche in mosaic cases50.0%
Spontaneous menarche in structural abnormalities45.5%
Autoimmune hypothyroidism prevalence in structural abnormalities46.9%

Key Findings

  • The majority of participants were diagnosed with classical monosomy (44.2%).
  • Significant differences in spontaneous menarche rates were observed: 4.3% in 45, X individuals vs. 50.0% in mosaic cases.
  • Autoimmune hypothyroidism was more prevalent in individuals with structural X-chromosome abnormalities (46.9%).
  • No significant association was found between karyotype and one-year growth hormone response.
  • Growth hormone treatment led to a significant increase in height standard deviation score, particularly in the first year.

Clinical Implications

Understanding the karyotype-phenotype associations in Turner syndrome can guide clinical discussions and management strategies. This knowledge is essential for setting realistic expectations for patients and families regarding growth and developmental outcomes.

Conclusion

The study provides valuable insights into the associations between karyotypes and clinical features in Turner syndrome, emphasizing the importance of early diagnosis and tailored management.

Related Resources & Content

  1. The Journal of Clinical Endocrinology & Metabolism, 2024 -- Management Strategies for Patients Diagnosed with Turner Syndrome
  2. Frontiers in Endocrinology, 2026 -- Balancing oncologic risk and fertility potential: a single-center study on Turner syndrome patients with Y chromosome material
  3. Frontiers in Endocrinology, 2026 -- Ovarian function and X chromosome tissue mosaicism in adolescents with Turner syndrome and ongoing spontaneous puberty
  4. The Journal of Clinical Endocrinology & Metabolism, 2024 -- Health Outcomes in Males with 45,X/46,XY Mosaicism Mirror Those Observed in Turner Syndrome
  5. Karyotype-specific cardiovascular and metabolic profiles in Turner syndrome: a retrospective echocardiographic study, 2026
  6. European Journal of Endocrinology -- 2024 Consensus on Turner Syndrome
  7. Karyotype-specific cardiovascular and metabolic profiles in Turner syndrome: a retrospective echocardiographic study | Orphanet Journal of Rare Diseases | Springer Nature Link
  8. Health-related quality of life of young adults with Turner syndrome following a long-term randomized controlled trial of recombinant human growth hormone | BMC Pediatrics | Springer Nature Link

Original Source(s)

Related Content